Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Long intergenic non-protein coding RNA 2925 (LINC02925) is an autonomously transcribed long non-coding RNA that does not overlap with protein-coding genes[1][3]. It belongs to the lincRNA family, which are longer than 200 nucleotides and do not encode proteins, but instead may regulate the expression of nearby or distant genes through various mechanisms such as chromatin remodeling, RNA stabilization, and transcriptional regulation[5][7]. There is no established evidence that LINC02925 is directly involved as a therapeutic target or biomarker, and its specific physiological or pathological functions have not been characterized in the peer-reviewed literature as of the current knowledge cutoff.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 2925 (LINC02925).